Alteplase

GPTKB entity

Statements (51)
Predicate Object
gptkbp:instanceOf gptkb:tissue_plasminogen_activator
gptkb:drug
gptkbp:administeredBy gptkb:physician
gptkbp:approvalYear 1987
gptkbp:approvedBy gptkb:FDA
gptkbp:ATCCode B01AD02
gptkbp:brand gptkb:Activase
gptkb:Actilyse
gptkbp:CASNumber 105857-23-6
gptkbp:category gptkb:tissue_plasminogen_activator
fibrinolytic drug
gptkbp:chemicalFormula C2569H3928N746O781S40
gptkbp:contraindication active internal bleeding
severe uncontrolled hypertension
recent intracranial surgery
gptkbp:developedBy gptkb:Genentech
gptkbp:discoveredBy gptkb:Genentech
gptkbp:eliminationHalfLife 4-6 minutes
gptkbp:essentialMedicine gptkb:WHO_Model_List_of_Essential_Medicines
gptkbp:excretion urine
gptkbp:firstApprovedCountry gptkb:United_States
https://www.w3.org/2000/01/rdf-schema#label Alteplase
gptkbp:indication gptkb:acute_myocardial_infarction
massive pulmonary embolism
acute ischemic stroke within 3-4.5 hours of onset
central venous catheter occlusion
gptkbp:legalStatus prescription only
off-patent
gptkbp:mechanismOfAction converts plasminogen to plasmin
gptkbp:metabolism liver
gptkbp:molecularWeight 59,050 Da
gptkbp:origin human protein
gptkbp:pregnancyCategory C (US)
gptkbp:producedBy recombinant DNA technology
gptkbp:product gptkb:protein
gptkbp:riskFactor allergic reaction
hypotension
angioedema
gptkbp:routeOfAdministration intravenous
gptkbp:sideEffect bleeding
intracranial hemorrhage
gptkbp:storage refrigerated
gptkbp:synonym gptkb:rtPA
recombinant tissue plasminogen activator
gptkbp:UNII QGJ20R72FS
gptkbp:usedFor myocardial infarction
pulmonary embolism
acute ischemic stroke
catheter clearance
gptkbp:bfsParent gptkb:Thrombolytics
gptkbp:bfsLayer 7